Days to regain birth weight · preterm infants
1 finding from 1 review
Number of TPN days · preterm infants
1 finding from 1 review
Neonatal mortality · preterm infants at risk of respiratory distress syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
BPD at 28 days · preterm infants at risk for bronchopulmonary dysplasia
It is very uncertain whether superoxide dismutase (SOD) changes BPD defined as an oxygen requirement at 28 days№ of participants:… compared with placebo (very low certainty).
1 finding from 1 review
RR 1.09 [0.94, 1.26]
Studies not reported
Very low
Neonatal mortality · preterm infants at risk for bronchopulmonary dysplasia
It is very uncertain whether superoxide dismutase (SOD) changes neonatal mortality (i.e. within 28 days)№ of participants: 335(2 RCTs) compared with placebo (very low certainty).
1 finding from 1 review
RR 0.98 [0.57, 1.68]
Studies not reported
Very low
Need for supplemental oxygen (days)№ of participants: 0 (0 RCTs) · preterm infants at risk for bronchopulmonary dysplasia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Complications within 30 days postoperatively · Patients with outcomes after colorectal cancer surgery
Prehabilitation showed no clear difference in complications within 30 days postoperatively compared with no prehabilitation (low certainty).
1 finding from 1 review
Incidence of (study author‐defined) suspected infection within the first 28 days of life · Neonates and caregivers
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Incidence of bacteriologically confirmed infection (types of infection as specified by study authors) within the first 28 days of life ‐ all infections · Neonates and caregivers
Two per cent CHG probably leads to lower incidence of bacteriologically confirmed infections (types of… compared with alcohol hand sanitiser (61% alcohol and emollients) (moderate certainty).
1 finding from 1 review
Early neonatal mortality · Neonates and caregivers
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Late neonatal mortality · Neonates and caregivers
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Incidence of (study author‐defined) suspected infection within the first 28 days of life · Neonates and caregivers
It is very uncertain whether alcohol‐based handrub changes incidence of suspected infections (author‐defined) within the first… compared with usual care (very low certainty).
1 finding from 1 review
Incidence of bacteriologically confirmed infection within the first 28 days of life · Neonates and caregivers
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Early neonatal mortality · Neonates and caregivers
It is very uncertain whether alcohol‐based handrub changes all‐cause mortality within the first seven days of life (early… compared with usual care (very low certainty).
1 finding from 1 review
Late neonatal mortality · Neonates and caregivers
It is very uncertain whether alcohol‐based handrub changes all‐cause mortality from the 8th to 28th day of life (late neonatal… compared with usual care (very low certainty).
1 finding from 1 review
Duration of hospital stay MCID: 1 day absolute difference · adults with renal stones
1 finding from 1 review
Risk of requiring allogeneic blood transfusion (30 days post‐surgery) · people undergoing definitive fixation of hip, pelvic and long bone fractures
Intravenous tranexamic acid may leads to lower risk of requiring allogeneic blood transfusion (30 days post‐surgery) compared with placebo (low certainty).
1 finding from 1 review
Re‐operation due to bleeding (7 days post‐surgery) ‐ not reported · people undergoing definitive fixation of hip, pelvic and long bone fractures
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Myocardial infarction (0 to 30 days) · people undergoing definitive fixation of hip, pelvic and long bone fractures
It is very uncertain whether topical tranexamic acid changes risk of myocardial infarction (30 days post‐surgery) compared with placebo (very low certainty).
1 finding from 1 review
Stroke · people undergoing definitive fixation of hip, pelvic and long bone fractures
It is very uncertain whether topical tranexamic acid changes risk of cerebrovascular accident/stroke (30 days post‐surgery) compared with placebo (very low certainty).
1 finding from 1 review